Dr. Zylberman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
635 W 165th St
New York, NY 10032Phone+1 212-305-5615
Education & Training
Icahn School of Medicine at Mount Sinai (Beth Israel)Fellowship, Addiction Psychiatry, 1998 - 1999
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Psychiatry, 1991 - 1994- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Psychiatry, 1987 - 1991
New York Downtown HospitalInternship, Internal Medicine, 1986 - 1987
Universidade de Sao Paulo Faculty of MedicineClass of 1980
Certifications & Licensure
NY State Medical License 1994 - 2025
PA State Medical License 1991 - 1996- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 66 citationsPreliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trialEduardo A. Leiderman, Ilana Zylberman, Stephen R. Zukin, Thomas B. Cooper, Daniel C. Javitt
Biological Psychiatry. 1996-02-01 - 8 citationsPharmacological augmentation of NMDA receptor function for treatment of schizophrenia.Ilana Zylberman, Daniel C. Javitt, Stephen R. Zukin
Annals of the New York Academy of Sciences. 1995-05-01 - 266 citationsAmelioration of negative symptoms in Schizophrenia by glycineDaniel C. Javitt, Ilana Zylberman, Stephen R. Zukin, Uriel Heresco-Levy, Jean-Pierre Lindenmayer
The American Journal of Psychiatry. 1994-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
